BR0211063A - Sais de derivados anticonvulsivantes - Google Patents

Sais de derivados anticonvulsivantes

Info

Publication number
BR0211063A
BR0211063A BR0211063-6A BR0211063A BR0211063A BR 0211063 A BR0211063 A BR 0211063A BR 0211063 A BR0211063 A BR 0211063A BR 0211063 A BR0211063 A BR 0211063A
Authority
BR
Brazil
Prior art keywords
salts
derivatives
anticonvulsant derivatives
anticonvulsant
anticonvulsing
Prior art date
Application number
BR0211063-6A
Other languages
English (en)
Inventor
Ahmed Abdel-Magid
Cynthia Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0211063(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of BR0211063A publication Critical patent/BR0211063A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

"SAIS DE DERIVADOS ANTICONVULSIVANTES". A invenção refere-se a sais farmaceuticamente aceitáveis de derivados anticonvulsivantes, processos para preparação de e composições farmacêuticas contendo os sais referidos, úteis no tratamento de epilepsia.
BR0211063-6A 2001-07-09 2002-07-03 Sais de derivados anticonvulsivantes BR0211063A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
BR0211063A true BR0211063A (pt) 2004-07-20

Family

ID=23174444

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211063-6A BR0211063A (pt) 2001-07-09 2002-07-03 Sais de derivados anticonvulsivantes

Country Status (27)

Country Link
US (2) US7098188B2 (pt)
EP (1) EP1414824B1 (pt)
JP (1) JP2005502629A (pt)
KR (1) KR20040013127A (pt)
CN (1) CN1288159C (pt)
AR (1) AR036137A1 (pt)
AT (1) ATE361304T1 (pt)
AU (1) AU2002346042B2 (pt)
BR (1) BR0211063A (pt)
CA (1) CA2452612A1 (pt)
DE (1) DE60219922T2 (pt)
DK (1) DK1414824T3 (pt)
ES (1) ES2284884T3 (pt)
HK (1) HK1064094A1 (pt)
HR (1) HRP20040017A2 (pt)
HU (1) HUP0401080A2 (pt)
IL (2) IL159698A0 (pt)
MX (1) MXPA04000232A (pt)
NO (1) NO20040066L (pt)
NZ (1) NZ530507A (pt)
PL (1) PL367635A1 (pt)
PT (1) PT1414824E (pt)
RU (1) RU2320665C2 (pt)
SI (1) SI21370A (pt)
UA (1) UA78211C2 (pt)
WO (1) WO2003006467A1 (pt)
ZA (1) ZA200400970B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
EP1450826A1 (en) * 2001-11-06 2004-09-01 Ortho-Mcneil Pharmaceutical Corp. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP1515703A1 (en) * 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
ES2238999T3 (es) * 1999-02-24 2005-09-16 University Of Cincinnati Uso de derivados de sulfamato para tratar trastornos en el control de los impulsos.
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
ES2284884T3 (es) 2007-11-16
AU2002346042B8 (en) 2003-01-29
DE60219922T2 (de) 2008-01-17
IL159698A (en) 2009-09-22
HK1064094A1 (en) 2005-01-21
US7098188B2 (en) 2006-08-29
AR036137A1 (es) 2004-08-11
IL159698A0 (en) 2004-06-20
EP1414824B1 (en) 2007-05-02
UA78211C2 (en) 2007-03-15
CA2452612A1 (en) 2003-01-23
AU2002346042B2 (en) 2007-10-18
US20060105966A1 (en) 2006-05-18
DK1414824T3 (da) 2007-07-16
PL367635A1 (en) 2005-03-07
JP2005502629A (ja) 2005-01-27
CN1551882A (zh) 2004-12-01
US20030069190A1 (en) 2003-04-10
SI21370A (sl) 2004-06-30
ZA200400970B (en) 2005-02-07
RU2004100274A (ru) 2005-06-20
ATE361304T1 (de) 2007-05-15
CN1288159C (zh) 2006-12-06
PT1414824E (pt) 2007-06-27
DE60219922D1 (de) 2007-06-14
NZ530507A (en) 2007-01-26
EP1414824A1 (en) 2004-05-06
WO2003006467A1 (en) 2003-01-23
NO20040066L (no) 2004-03-01
MXPA04000232A (es) 2005-03-07
HUP0401080A2 (hu) 2004-09-28
HRP20040017A2 (en) 2004-10-31
KR20040013127A (ko) 2004-02-11
RU2320665C2 (ru) 2008-03-27

Similar Documents

Publication Publication Date Title
BR0211063A (pt) Sais de derivados anticonvulsivantes
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
BR0015188A (pt) Composições farmacêuticas
MXPA03007712A (es) Sales farmaceuticas.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BRPI0817275A2 (pt) Combinação farmacêutica de alisquireno e valsartana
SE0102440D0 (sv) New compound
BR9916887A (pt) Uso de derivados de pirimidina
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
BR0011845A (pt) Complexo farmacêutico
DK1411956T3 (da) Anvendelse af oversulfaterede polysaccharider som inhibitorer af HIV
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
DK0863752T3 (da) Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.
DK1399141T3 (da) Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
BRPI0414423A (pt) inibidores de pace4, suas composições farmacêuticas e respectivos usos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: JOHNSON & JOHNSON (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE A 8.6, DA RPI 2108 DE 31/05/2011.